Autoprothrombin IIA
Autoprothrombin IIA Uses, Dosage, Side Effects, Food Interaction and all others data.
Autoprothrombin IIA is an endogenously occurring plasma protein that plays a key role within the coagulation cascade. Autoprothrombin IIA is a zymogen, or enzyme precursor, of a vitamin K-dependent anticoagulant glycoprotein (serine protease) that is synthesized in the liver. It is converted by the thrombin/thrombomodulin-complex on the endothelial cell surface to Activated Autoprothrombin IIA (APC). Once in its activated form, APC functions as a serine protease with potent anticoagulant effects, especially in the presence of its cofactor protein S. APC exerts its effect by inactivating essential components of the coagulation cascade (specifically factors V and VIII), which leads to a decrease in thrombin formation, and therefore a reduction in clot formation.
The Autoprothrombin IIA pathway provides a natural mechanism for control of the coagulation system and prevention of excessive procoagulant responses to activating stimuli. A lack of protein C in the body would lead to unchecked coagulation activation, resulting in thrombin generation and intravascular clot formation.
Autoprothrombin IIA is available in concentrated form as the product Ceprotin, which is indicated for use in pediatric and adult patients with severe congenital protein C deficiency for the prevention and treatment of venous thrombosis and purpura fulminans.
Trade Name | Autoprothrombin IIA |
Generic | Protein C |
Protein C Other Names | autoprothrombin IIA, blood coagulation factor XIV, Human protein C, Protein C (coagulation inhibitor), Protein C concentrate, Protein C concentrate (human), Protein C concentrate human, Protein C human |
Type | |
Groups | Approved |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Autoprothrombin IIA is a medication used to treat protein C deficiency leading to purpura fulminans or coumarin-induced skin necrosis.
Autoprothrombin IIA concentrate is indicated for pediatric and adult patients with severe congenital protein C deficiency for the prevention and treatment of venous thrombosis and purpura fulminans. It is also found as a component of some prothrombin complex concentrate (i.e. Factor IX Complex (Human)) formulations, such as Kcentra.
Autoprothrombin IIA is also used to associated treatment for these conditions: Purpura Fulminans, Thrombosis, Venous
How Autoprothrombin IIA works
Autoprothrombin IIA is an endogenously occurring plasma protein that plays a key role within the coagulation cascade. Also known as blood coagulation factor XIV, Autoprothrombin IIA is a zymogen, or enzyme precursor, of a vitamin K-dependent anticoagulant glycoprotein (serine protease) that is synthesized in the liver. It is converted by the thrombin/thrombomodulin-complex on the endothelial cell surface to Activated Autoprothrombin IIA (APC). Once in its activated form, APC functions as a serine protease with potent anticoagulant effects, especially in the presence of its cofactor protein S. APC exerts its effect by inactivating essential components of the coagulation cascade (specifically factors V and VIII), which leads to a decrease in thrombin formation, and therefore a reduction in clot formation.
Food Interaction
- Avoid herbs and supplements with anticoagulant/antiplatelet activity. Examples include garlic, ginger, bilberry, danshen, piracetam, and ginkgo biloba.
Volume of Distribution
Volume of distribution at steady state = 0.74 dL/kg
Elimination Route
Cmax = 110 IU/dL Tmax = 0.50 hr
Half Life
Initial half life = 7.8 hr Terminal half life = 9.9 hr
Clearance
CL = 0.0533 dL/kg/h
Innovators Monograph
You find simplified version here Autoprothrombin IIA